Tarsus Pharmaceuticals TARS
NASDAQ TARS
$76.76 +2.93 (+3.97%)
At close: Nov 11, 2026 · 4:00 PM EST

Tarsus Pharmaceuticals (TARS) Other Accumulated Expenses (2020)

Updated

Tarsus Pharmaceuticals' Other Accumulated Expenses came in at $447,000 for Q3 2020.

Analysis

Tarsus Pharmaceuticals (TARS) Other Accumulated Expenses (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Tarsus Pharmaceuticals 3.64 Bn 2.07 Bn 180.68 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 447,000.00
API Access

Tarsus Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=TARS&period=max&api_key=YOUR_API_KEY